TORONTO, Oct. 2, 2017 /CNW/ - Acerus Pharmaceuticals
Corporation (TSX:ASP) announced today that Mr. Tom Rossi, President and Chief Executive
Officer, will depart from the Company on October 2, 2017 to pursue other
opportunities.
I would like to take this opportunity to thank Tom for his many
contributions and leadership during his tenure as CEO as he leaves
the Company in a very strong position for future growth", said
Ian Ihnatowycz, Chairman of the
Board. "The board wishes Tom much success with his future
endeavors".
An interim CEO, Luc Mainville,
has been appointed from the board until the recruitment of a new
CEO takes place. "I am excited to take the helm of the company at
this time", said Luc Mainville. "We
have a great team at Acerus and I have been part of building the
team as a board member over the last year. We have all the elements
in place and look to the future with optimism and confidence".
Mr. Mainville is the Chair of the board of directors of Zucara
Therapeutics Inc. Previously, Mr. Mainville served as Executive
Vice President for Cardiome Pharma Corp. as well as President and
Chief Executive Officer of Neopharm Labs Inc. and prior to that LAB
Research Inc. He has gained considerable experience throughout his
career in senior management, operational and corporate finance
roles, and served as a director for a number of public and private
companies in the biotechnology and pharmaceutical sectors. In
particular, Mr. Mainville has led in excess of 20 public company
financing transactions, totaling funds raised in excess of
$200 million, as well as served as
Chair and Chair of the Audit Committee for a number of Boards. He
served as Vice-Chairman of BioteCanada and, prior to his career in
the life science industry, Mr. Mainville was a Senior Vice
President and Partner at KPMG.
About Acerus
Acerus Pharmaceuticals Corporation is a fully-integrated,
Canadian specialty pharmaceutical company engaged in the
development, manufacture, marketing and distribution of innovative,
branded products in Men's and Women's Health. Acerus' shares trade
on TSX under the symbol ASP. For more information, visit
www.aceruspharma.com and follow us on Twitter and
LinkedIn.
SOURCE Acerus Pharmaceuticals Corporation
